New opportunities in collagen: Breakthrough science, mobility insights and inspiring functional food formats

Innovating with collagen? Science is what will get you ahead. In this presentation, Bioiberica’s Daniel Martínez-Puig, Head of R&D for Human Health, shares newly published clinical research on Collavant® n2 native (undenatured) type II collagen revealing its potential to drive innovation in the joint health and mobility market. Join the session to discover:

    • Hot-off-the-press freshly published data showing that 40 g/day Collavant® n2 may support articular cartilage in healthy individuals with activity-related joint      discomfort.

    • Evidence that Collavant® n2 can improve joint comfort and reduce recovery time in healthy, active consumers.

    • New functional food concepts, like collagen-enriched milk drinks.